FIGURE 3. Decision tree for genotyping for CYP2D6.

FIGURE 3Decision tree for genotyping for CYP2D6

The Markov model referenced in this figure is depicted in Figure 4.

From: 4, Assessment of cost-effectiveness

Cover of The Clinical Effectiveness and Cost-Effectiveness of Genotyping for CYP2D6 for the Management of Women with Breast Cancer Treated with Tamoxifen: A Systematic Review
The Clinical Effectiveness and Cost-Effectiveness of Genotyping for CYP2D6 for the Management of Women with Breast Cancer Treated with Tamoxifen: A Systematic Review.
Health Technology Assessment, No. 15.33.
Fleeman N, Saborido CM, Payne K, et al.
Southampton (UK): NIHR Journals Library; 2011 Sep.
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.